Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVUMENIB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

47.6%
Female
52.4%
Male

Age Information

The average age of patients reporting adverse events with REVUMENIB is 46.4 years.

Geographic Distribution

The majority of adverse event reports for REVUMENIB originate from US.

Report Summary & Outcomes

371
Total Reports
371
As Primary/Secondary Suspect
49
Deaths Reported
93
Hospitalizations
1
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 20241101. Most recent report: 20250922. View full timeline →

More About REVUMENIB

REVUMENIB Full Profile Reports by Year Drug Interactions